A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.
about
High rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial.Enhancing vaccine safety capacity globally: A lifecycle perspectivePrevalence of Human Immunodeficiency Virus, Hepatitis B and Hepatitis C Virus Antibodies and Hepatitis B Antigen Among Commercial Sex Workers in JapanIncidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity areaSpatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean BasinTime trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.Update on diagnosis, management, and prevention of hepatitis B virus infection.Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.Arsphenamine jaundice and the recognition of instrument-borne virus infection.The woodchuck model of hepatitis B virus infection.Current and Future Burden of Chronic Nonmalignant Liver DiseaseInfectious disease experimentation involving human volunteers.Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Viral hepatitis: past and future of HBV and HDV.Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.Relationship of human leukocyte antigen class II genes with the susceptibility to hepatitis B virus infection and the response to interferon in HBV-infected patientsEpidemiology of hepatitis B in the United States.Yellow fever vaccine.Recent epidemiological and clinical features of acute hepatitis B in a single center of China.The association of complex liver disorders with HBV genotypes prevalent in PakistanHepatitis B markers in Lancashire police officersIncidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.Medical virology of hepatitis B: how it began and where we are nowHepatitis B virus infection and transfusion medicine: science and the occult.Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysisImmunological mechanisms of hepatitis B virus persistence in newborns.Advances and controversies in yellow fever vaccinationPrevalence of hepatitis B infection among young and unsuspecting Hmong blood donors in the Central California Valley.Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?A brief history of hepatitis milestones.Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV.Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B virus in Iran.Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay.Blood system changes since recognition of transfusion-associated AIDS.[History of viral hepatitis].Seroprevalence of hepatitis B among pregnant women in Varna Region, Bulgaria.Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc.Rationally respond to post-vaccination adverse events.Cost-benefit analysis of hepatitis-B vaccination. A computerized decision model for Spain.Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts.
P2860
Q24814210-5603C436-D205-465C-84F6-845D904516FFQ26782451-7108D045-0572-4FCE-8E45-C6B6183C52CEQ27478009-6ADA29B2-00BC-4F8D-B5CE-36A04AA0D972Q28397139-2686198B-9D79-478D-9316-50C7059A8AFBQ28483949-29374DB0-98C3-4B2C-950A-DE8FE9746D05Q33577032-8A07B6D8-248B-47E1-B4D4-688F3CE4E3E1Q33588921-E508E3E4-ECA3-408D-A313-65DD7BEE2084Q33877518-433208EB-CAE5-4B48-BBB9-763EB84C6700Q33935573-34C31F22-554C-43B6-9201-24CF2D2918BEQ34282796-58DDC2A9-D5EA-432D-9FB6-A60CB125CF0DQ34490300-28F4A4CF-E38E-499A-9A42-8E29317D9793Q34553532-9BAE706F-744B-41B6-86EC-083962102C7CQ34606036-8D20D35B-0273-45F3-8ECC-4C5CF56908F7Q35045045-24FE4C92-7AB1-46E7-A178-4E141E3AAAEAQ35632910-367E9360-1997-4C29-BAC7-CFA6D6B33161Q35784161-9C893D80-74AB-406E-A3AF-97AA58F023A6Q35792051-6B2E2B24-92CB-4C19-A77E-4E8936ADABD5Q36238729-462146E5-28B4-4E17-8C2B-683CA901E467Q36318130-9A74F50F-88C4-4D17-9955-6FA34D1C2458Q36402124-B8E40477-E99D-4194-B58D-8E093C7BE605Q36472458-CEF1DDE1-194E-4F56-9DFC-EBA2B31EB824Q36548225-C7918AE0-643A-4DD3-AD47-F27B4B1E9EFCQ37059714-7FAC34E1-3A90-43D4-A011-5302EE2B6EB6Q37153782-71E85052-AE00-45D2-88D5-23C10633068BQ37458983-A0011919-9817-4727-B27A-FEF2139F1CB3Q37592372-A10C0B7C-8D3E-480E-B7BE-4C6806AA7F36Q37709619-D3352267-057B-4DE3-8DC7-2A42D5A67F60Q37904777-DAB6F529-369F-4B44-BE04-FC885C6FE39CQ37958234-393BDDDC-8E8A-467A-91A0-CA84FBEFD5C3Q38174247-8347CDCF-BE91-47C3-827A-CD7C57CDCA4DQ38824634-B7C39662-1052-486D-974A-48B9D6910DFFQ38856750-C6D18B78-F45E-4EF2-845F-990AB2DC4219Q40211473-C1EFF86D-95B3-43BD-AED5-89A72E57F095Q40234714-385E86D5-8509-4659-9C6E-735CD0C42B8CQ40356027-0E97409C-42FE-4698-A6C3-5DBF0F9B49BFQ40365576-778EC6CD-692C-4842-B685-6FAB0BBAB668Q40974197-EA4F20D7-1D32-4257-9894-EFFF06CE47B6Q42228471-45256058-AE3C-46A5-B16A-3ACE969E1EBAQ45044214-0388F6E7-4F07-4D39-95DA-FE07535E3D6FQ45369749-710AC4BB-EAE1-4BDE-B67C-1371E55492A3
P2860
A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
A serologic follow-up of the 1 ...... tis in the United States Army.
@en
type
label
A serologic follow-up of the 1 ...... tis in the United States Army.
@en
prefLabel
A serologic follow-up of the 1 ...... tis in the United States Army.
@en
P2093
P1476
A serologic follow-up of the 1 ...... tis in the United States Army.
@en
P2093
Buskell-Bales Z
Hoofnagle JH
Kaplowitz N
Petrini JL Jr
Waggoner JG
P304
P356
10.1056/NEJM198704163161601
P407
P577
1987-04-01T00:00:00Z